Seer’s (SEER) Sell (D-) Rating Reiterated at Weiss Ratings

Seer (NASDAQ:SEER)‘s stock had its “sell (d-)” rating reiterated by Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Seer Trading Up 1.4%

Shares of SEER stock opened at $2.25 on Wednesday. Seer has a 1 year low of $1.62 and a 1 year high of $2.63. The firm’s 50 day moving average is $2.13 and its 200-day moving average is $2.06. The firm has a market capitalization of $126.77 million, a price-to-earnings ratio of -1.62 and a beta of 1.59.

Seer (NASDAQ:SEER) last issued its earnings results on Wednesday, August 6th. The company reported ($0.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.39) by $0.06. The company had revenue of $4.05 million for the quarter, compared to analyst estimates of $3.75 million. Seer had a negative net margin of 506.15% and a negative return on equity of 25.10%. On average, equities research analysts forecast that Seer will post -1.42 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Seer news, CEO Omid Farokhzad sold 33,992 shares of Seer stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $2.04, for a total value of $69,343.68. Following the transaction, the chief executive officer owned 1,272,068 shares of the company’s stock, valued at approximately $2,595,018.72. The trade was a 2.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 11.28% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SEER. Occudo Quantitative Strategies LP bought a new position in Seer in the second quarter valued at approximately $25,000. Quadrature Capital Ltd acquired a new stake in shares of Seer in the second quarter valued at approximately $47,000. OMERS ADMINISTRATION Corp raised its holdings in shares of Seer by 54.3% in the first quarter. OMERS ADMINISTRATION Corp now owns 76,200 shares of the company’s stock valued at $129,000 after purchasing an additional 26,819 shares during the last quarter. Corient Private Wealth LLC raised its holdings in shares of Seer by 46.3% in the second quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock valued at $135,000 after purchasing an additional 20,000 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of Seer in the second quarter valued at approximately $172,000. Institutional investors own 75.20% of the company’s stock.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.